in J. Antimicrob. Chemother. as of November 1, 2009 -- updated monthly
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 1. | K Hiramatsu, H Hanaki, T Ino, K Yabuta, T Oguri, FC Tenover | ||
 |
|
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility | |
|---|---|---|---|
|
|
J Antimicrob Chemother Jul 01, 1997; 40: 135-136.
(In "Letters") |
|
|
|
||
| 2. | Jennifer M. Andrews | ||
|
|
Determination of minimum inhibitory concentrations | |
|
|
J Antimicrob Chemother Jul 01, 2001; 48: 5-16.
(In "Supplements") |
|
|
|
||
| 3. | ROSAMOND A. COX | ||
|
|
Amantadine prophylaxis for health care workers: unanswered questions | |
|
|
J Antimicrob Chemother Jan 01, 1991; 27: 1-3.
(In "Leading articles") |
|
|
|
||
| 4. | Helena Seppälä, Antti Nissinen, Quan Yu, Pentti Huovinen | ||
|
|
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland | |
|
|
J Antimicrob Chemother Dec 01, 1993; 32: 885-891.
(In "Brief reports") |
|
|
|
||
| 5. | David M. Livermore, Rafael Canton, Marek Gniadkowski, Patrice Nordmann, Gian Maria Rossolini, Guillaume Arlet, Juan Ayala, Teresa M. Coque, Izabela Kern-Zdanowicz, Francesco Luzzaro, Laurent Poirel, Neil Woodford | ||
|
|
CTX-M: changing the face of ESBLs in Europe | |
|
|
J Antimicrob Chemother Feb 01, 2007; 59: 165-174.
(In "Reviews") |
|
|
|
||
| [Next 5 Articles] | |||
Subscribe to Most Cited feed
Last Updated: 11/18/2009 10:02:33